Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
As a new crypto investor, it's crucial to know what to watch out for to avoid costly mistakes. Equip yourself with knowledge to navigate the market safely.
27,825 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
A mobile platform that pays users to scroll is gaining momentum as it cracks Deloitte’s fastest-growing software rank...
A quiet quantum player is showing real-world traction while the hype focuses on the big names. This analysis reveals ...
A hypothetical SpaceX IPO could ride a powerful tailwind if a Google cloud deal brings $30 billion in AI compute reve...
In the first half of 2026, texas pacific land corporation rose by roughly half, powered by oil-and-gas price momentum...
As Xometry heads into 2025 earnings, investors seek clarity on growth, margins, and execution. This guide provides ac...
Investors are weighing the latest earnings from D-Wave Quantum. While losses persisted, revenue beat expectations in ...
Frequency Electronics stock plummeting has traders watching closely. This guide breaks down the causes, what it means...
As the VIX climbs and markets wobble, a small group of overlooked stocks has kept delivering. Here are the five names...
As 2026 unfolds, investors are weighing which bank stocks offer durable growth and solid risk controls. This guide br...
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Braze stock sinking today followed a quarterly report that topped revenue expectations but left investors concerned a...